| 000 | 04955cam a2200613Ii 4500 | ||
|---|---|---|---|
| 005 | 20250930143106.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 190918t20182018gw ob 001 0 eng d | ||
| 020 |
_a9783527699896 _q(electronic bk.) |
||
| 020 |
_a3527699899 _q(electronic bk.) |
||
| 020 |
_a9783527699902 _q(electronic bk. : oBook) |
||
| 020 |
_a3527699902 _q(electronic bk. : oBook) |
||
| 020 | _z9783527340637 | ||
| 020 | _z3527340637 | ||
| 035 |
_a(OCoLC)1004271395 _z(OCoLC)1004364574 |
||
| 035 | _a(OCoLC)on1004271395 | ||
| 039 | 9 |
_a201911050903 _bmurni _y09-18-2019 _zhafiz _wUKM UBCM Wiley MARC (363 titles).mrc _x333 |
|
| 040 |
_aNST _beng _erda _epn _cNST _dEBLCP _dNST _dOCLCF _dDG1 _dYDX _dMERER |
||
| 049 | _aMAIN | ||
| 050 | 4 | _aRS380 | |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615.7 _223 |
| 245 | 0 | 0 |
_aContinuous biomanufacturing : _binnovative technologies and methods / _cedited by Ganapathy Subramanian. |
| 264 | 1 |
_aWeinheim : _bWiley-VCH, _c[2018] |
|
| 264 | 4 | _cò018 | |
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aContinuous Biomanufacturing: Innovative Technologies and Methods; Contents; List of Contributors; Part One: Overview of State-of-the-Art Technologies and Challenges; Chapter 1: Continuous Bioprocess Development: Methods for Control and Characterization of the Biological System; 1.1 Proposed Advantages of Continuous Bioprocessing; 1.1.1 Introduction; 1.2 Special Challenges for Continuous Bioprocesses; 1.2.1 The Biological System in Continuous Biomanufacturing; 1.2.2 Inherent Changes in the Microbial System -- Problem of Evolution; 1.2.3 Lack of Process Information | |
| 505 | 8 | _a1.2.3.1 Models-Based Process Development and Control for Continuous Processes1.2.3.2 Engineering Approach to Complex Systems; 1.2.4 Limited Control Strategies; 1.2.4.1 Traditional Control Strategies for Continuous Cultures; 1.3 Changes Required to Integrate Continuous Processes in Biotech; 1.3.1 A Better Physiological Understanding of the Organisms and Their Responses on the Reactor Environment; 1.3.1.1 Model Complexity; 1.3.1.2 Models; 1.3.2 Model-Based Process Monitoring; 1.3.3 Implementation of Model Predictive Control; 1.3.3.1 Model-Based Control | |
| 505 | 8 | _a1.4 Role of Iterative Process Development to Push Continuous Processes in Biotech1.4.1 Methods for Development of Continuous Processes; 1.4.1.1 Alternative: Fed-Batch as a System to Simulate Quasi Steady-State Conditions; 1.4.2 Mimicking Industrial Scale Conditions in the Lab: Continuous-Like Experiments; 1.4.2.1 A Simple Model for Continuous Processes; 1.4.2.2 Continuous-Like Fed-Batch Cultivations; 1.4.3 Fast and Parallel Experimental Approaches with High Information Content; 1.4.3.1 Computer-Aided Operation of Robotic Facilities; 1.4.3.2 Model Building and Experimental Validation | |
| 505 | 8 | _a1.5 ConclusionsReferences; Chapter 2: Tools Enabling Continuous and Integrated Upstream and Downstream Processes in the Manufacturing of Biologicals; 2.1 Introduction; 2.2 Continuous Upstream Processes; 2.2.1 Continuous Bioprocesses: With or Without Cell Recycle?; 2.2.2 Early/Scale-Down Perfusion Development; 2.2.3 Feeding and Operational Strategies in Perfusion Processes; 2.2.4 Cell Retention Devices; 2.3 Continuous Downstream Processes; 2.3.1 Continuous Liquid Chromatography (CLC); 2.3.1.1 Continuous Annular Chromatography (CAC) | |
| 505 | 8 | _a2.3.1.2 True and Simulated Moving Bed Chromatography (TMB/SMB)2.3.1.3 Multicolumn Countercurrent Solvent Gradient Purification (MCSGP); 2.3.1.4 Periodic Countercurrent Chromatography (PCC); 2.3.1.5 Continuous Countercurrent Tangential Chromatography (CCTC); 2.3.2 Nonchromatographic Continuous Processes; 2.3.2.1 Continuous Aqueous Two-Phase Systems; 2.3.2.2 Continuous Protein Precipitation; 2.3.3 Straight-Through Processes; 2.3.4 Continuous Virus Clearance Processes; 2.4 Integrated Continuous Processes; 2.5 Concluding Remarks; References | |
| 588 | 0 | _aOnline resource; title from PDF title page (EBSCO, viewed September 29, 2017). | |
| 590 |
_aJohn Wiley and Sons _bWiley Online Library All Obooks |
||
| 650 | 0 |
_aPharmaceutical biotechnology. _960734 |
|
| 650 | 0 | _aBiopharmaceutics. | |
| 650 | 0 | _aBiochemical engineering. | |
| 655 | 4 | _aElectronic books. | |
| 655 | 0 | _aElectronic books. | |
| 700 | 1 |
_aSubramanian, G., _d1935- _eeditor. |
|
| 773 | 0 | _tWiley e-books | |
| 776 | 0 | 8 |
_cOriginal _z3527340637 _z9783527340637 _w(OCoLC)967719361 |
| 856 | 4 | 0 |
_uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=https://doi.org/10.1002/9783527699902 _zWiley Online Library |
| 907 |
_a.b16758316 _b2022-08-18 _c2019-11-12 |
||
| 942 | _n0 | ||
| 914 | _avtls003651488 | ||
| 998 |
_ae _b2019-05-09 _cm _dz _feng _ggw _y0 _z.b16758316 |
||
| 999 |
_c643718 _d643718 |
||